{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:44:43Z","timestamp":1784551483885,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.amjcard.2018.01.043","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T12:19:35Z","timestamp":1518437975000},"page":"1192-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"121","author":[{"given":"Moussa","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kevin","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jared","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Karst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Ruskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijoy","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.01.043_bib0010","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0015","first-page":"257","article-title":"Atrial fibrillation: the most common arrhythmia","volume":"27","author":"Wyndham","year":"2000","journal-title":"Texas Heart Inst J"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0030","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0035","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0040","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.112.092494","article-title":"Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation: clinical perspective","volume":"126","author":"Tsadok","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0045","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0050","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.114.014092","article-title":"Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) S","volume":"132","author":"Reddy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0060","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jacc.2005.07.046","article-title":"Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system","volume":"46","author":"Sarabanda","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jacc.2014.04.072","article-title":"Catheter ablation with a contact force sensing catheter","volume":"64","author":"Natale","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1540-8167.2006.00616.x","article-title":"Integration of cardiac CT\/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation","volume":"17","author":"Malchano","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacep.2016.06.002","article-title":"The impact of first procedure success rate on the economics of atrial fibrillation ablation","volume":"3","author":"Mansour","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","article-title":"Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation","volume":"22","author":"Bunch","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/eurjhf\/hfq083","article-title":"Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR","volume":"12","author":"Cleland","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-6419.2007.00527.x","article-title":"Some practical guidance for the implementation of propensity score matching","volume":"22","author":"Caliendo","year":"2008","journal-title":"J Econ Surv"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/pgmj.70.825.492","article-title":"Side effects with amiodarone therapy","volume":"70","author":"Shukla","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0735-1097(90)90251-J","article-title":"Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects","volume":"15","author":"Guccione","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/14740338.2012.722994","article-title":"Drug safety evaluation of dronedarone in atrial fibrillation","volume":"11","author":"De Ferrari","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0110","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3892\/etm.2015.2545","article-title":"Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"10","author":"Shi","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0115","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: clinical perspective","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"(RAAFT-2) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0130","doi-asserted-by":"crossref","first-page":"i2868","DOI":"10.1136\/bmj.i2868","article-title":"Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial","volume":"353","author":"Focks","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archinternmed.2012.2266","article-title":"Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation","volume":"172","author":"Ionescu-Ittu","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2018.01.043_bib0145","first-page":"255","article-title":"The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial","volume":"36","author":"Aliot","year":"2015","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918301875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918301875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:39:56Z","timestamp":1655782796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918301875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0002914918301875"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.043","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733235095.793547506","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}